Cabaletta Bio, Inc. (CABA)
2.00
+0.11
(+5.82%)
USD |
NASDAQ |
Oct 02, 16:00
2.02
+0.02
(+1.00%)
Pre-Market: 08:59
Cabaletta Bio Net Income (Quarterly) : -51.02M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -51.02M |
| March 31, 2026 | -43.52M |
| December 31, 2025 | -41.92M |
| September 30, 2025 | -44.87M |
| June 30, 2025 | -45.13M |
| March 31, 2025 | -35.94M |
| December 31, 2024 | -32.59M |
| September 30, 2024 | -30.63M |
| June 30, 2024 | -27.60M |
| March 31, 2024 | -25.05M |
| December 31, 2023 | -20.89M |
| September 30, 2023 | -16.45M |
| June 30, 2023 | -14.49M |
| March 31, 2023 | -15.85M |
| December 31, 2022 | -15.69M |
| Date | Value |
|---|---|
| September 30, 2022 | -11.43M |
| June 30, 2022 | -12.91M |
| March 31, 2022 | -12.95M |
| December 31, 2021 | -13.89M |
| September 30, 2021 | -11.56M |
| June 30, 2021 | -11.14M |
| March 31, 2021 | -9.702M |
| December 31, 2020 | -9.309M |
| September 30, 2020 | -8.393M |
| June 30, 2020 | -8.152M |
| March 31, 2020 | -7.485M |
| December 31, 2019 | -5.403M |
| September 30, 2019 | -4.65M |
| December 31, 2018 | -1.905M |
| September 30, 2018 | -9.276M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
| Curis, Inc. | -8.581M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 51.02M |
| EPS Diluted (Quarterly) | -0.3375 |
| Enterprise Value | 136.06M |
| Earnings Yield | -79.09% |
| Normalized Earnings Yield | -79.10 |